Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue: +4.15%
EPS: +49.0%
Free cash flow: +49.8%
Total debt: +80.0%

Quarter to September 2026, against a year earlier

209.82 16.72 −7.38%

Follow ILMN

Alert me

Market cap: $31.5B
P/E: 35.6×
Fwd P/E: 46.4×
Dividend yield: —
F-score: 8/9
Altman Z: 4.39
Beneish M: −2.51
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Illumina, Inc. (ILMN) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Illumina, Inc. (ILMN) trades at a P/E ratio of 35.6×. Over the past ten years it has ranged from 0.0× (June 2025) to 111× (February 2021); the current reading is higher than 37% of that period. That is in line with the Diagnostics & Research industry median of 34.5× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ILMN/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Illumina, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ILMN/metrics/pe-ratio">Illumina, Inc. (ILMN) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	23.9×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	73.4×	(9.50%)
FY2020	81.1×	69.54%
FY2019	47.8×	(8.72%)
FY2018	52.4×	19.11%
FY2017	44.0×	7.64%
FY2016	40.9×	(30.17%)

Period	P/E ratio	Change
Sep 2026	46.5×	42.97%
Jun 2026	32.5×	45.81%
Mar 2026	22.3×	(6.87%)
Dec 2025	23.9×	12.65%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 111×

Ten-year median 45.2×

Current reading's percentile 18

Company	P/E ratio
GH Guardant Health, Inc. compare	n/m
DGX Quest Diagnostics Incorporated compare	25.0×
LH Labcorp Holdings Inc. compare	29.5×
IQV IQVIA Holdings Inc. compare	31.8×
A Agilent Technologies, Inc. compare	33.8×
ILMN Illumina, Inc.	35.6×
MTD Mettler-Toledo International, Inc. compare	37.6×
IDXX IDEXX Laboratories, Inc. compare	44.8×
WAT Waters Corporation compare	194×
Diagnostics & Research industry median	34.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Illumina, Inc. (ILMN) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ILMN

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ILMN

Stockrow Weekly